Evosep ApS: Financial statements 2019
CVR: 37510068
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Evosep ApS (CVR 37510068) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 9,017,025 and a net result of DKK -141,196 compared with DKK -4,951,102 the year before. That is an increase of 259.3% compared with the year before. Equity in the 2019 report amounted to DKK 22,369,143. The solvency ratio was 92.8%.
- Gross Profit
- DKK 9,017,025
- Profit/Loss
- DKK -141,196
- Equity
- DKK 22,369,143
- Total Assets
- DKK 24,116,053
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 9 mio. | -141 t. | 22.4 mio. | - |
| 2018 | - | 2.5 mio. | -5 mio. | 22.5 mio. | - |
| 2017 | - | -2.7 mio. | -8.6 mio. | 7.2 mio. | - |
| 2016 | - | -1.2 mio. | -4.2 mio. | 7.9 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Evosep ApS has published its annual report for 2018. Gross profit came to DKK 2,509,519, and the net result was DKK -4,951,102.
About Evosep ApS
Evosep ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Omics Ready Biosystems ApS. The management consists of Morten Bern. The board consists of Stefan Karl Dieter Wolf (chair), Jens Bornhøft Christensen and Morten Bern. The company is owned by Paradigm BidCo ApS. The company has 16 employees (2018). In 2025, the company reported a gross profit of DKK 72,369,000 and a net result of DKK -221,637,000 compared with DKK -2,613,000 the year before. Equity in the 2025 report amounted to DKK 154,548,000.